{"id":27471,"date":"2026-11-22T04:03:53","date_gmt":"2026-11-22T04:03:53","guid":{"rendered":"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/"},"modified":"2026-11-22T04:05:02","modified_gmt":"2026-11-22T04:05:02","slug":"medibank-business-model-2026","status":"publish","type":"post","link":"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/","title":{"rendered":"Medibank Business Model in 2026"},"content":{"rendered":"<p>Medibank Private Limited (ASX: MPL) is an Australian health insurer and healthcare services group. This 2026 analysis draws financial and operational information from its FY2025 Annual Report for the year ended 30 June 2025. All financial amounts are in Australian dollars.<\/p>\n<h2>1. Insurance and the customer problem<\/h2>\n<p>Private health insurance helps households manage the cost and access arrangements of eligible hospital treatment and extras services. Medibank operates two insurance brands, Medibank and ahm, serving different customer preferences. In FY2025 the group supported more than 4.2 million health insurance customers and held 26.5% of the resident policyholder market. The scale is important because insurers pool contributions across many customers and pay eligible claims as health needs arise. Customers buy cover before knowing exactly which treatments they will require, creating a financial protection proposition.<\/p>\n<p>The insurer&#8217;s challenge is to price premiums responsibly while meeting claims obligations and maintaining accessible coverage. It cannot simply reject higher-risk resident applicants or freely set premium increases: community-rating requirements, risk equalisation and ministerial approval of premiums shape the business. Customers also judge cover on out-of-pocket costs, exclusions, waiting periods, service and provider access. A product that appears affordable but is poorly understood can lead to disappointment at claim time. Medibank therefore competes through benefit design, customer experience and healthcare partnerships as well as headline premiums.<\/p>\n<p>FY2025 health insurance revenue reached A$8,011.7 million and the group paid A$6.6 billion in claims. These measures illustrate the scale of insurance obligations, but should not be reduced to a simple profit calculation because administrative costs, insurance accounting and capital requirements also matter.<\/p>\n<p><strong>Related articles:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>2. Two brands and insurance economics<\/h2>\n<p>The Medibank brand offers health cover alongside a wider health and wellbeing proposition. ahm focuses on simpler, more straightforward cover and a value-oriented customer experience. This dual-brand approach allows the group to address different customer needs without presenting identical products to everyone. At 30 June 2025 resident policyholders numbered approximately 2.003 million, up 1.4%, including 1.440 million Medibank policyholders and 564,000 ahm policyholders. A policyholder count is not the same as the number of covered individuals because family policies can cover multiple people.<\/p>\n<p>Insurance economics depend on earned premiums less claims and operating expenses, together with investment income and capital requirements. FY2025 health insurance revenue was A$8,011.7 million, up 5.1%. The group paid A$6.6 billion in claims. Health Insurance operating profit increased 7.1% to A$741.5 million. These figures should not be interpreted as a simple premium-minus-claims calculation: insurance accounting includes recognition and allocation rules, and operating profit reflects additional costs and adjustments. Strong results depend on customer retention, pricing discipline, claims trends and efficient administration.<\/p>\n<p>Medibank reported 2.003 million resident policyholders and 4.2 million total insured customers. The figures represent different units of measurement: policies may cover more than one person. Growth in policyholders supports scale, but value also depends on retention, claims experience and customer service.<\/p>\n<p><strong>Related articles:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>3. Retention, acquisition and health engagement<\/h2>\n<p>The company added approximately 27,900 net resident policyholders during FY2025, representing 1.4% growth. Its acquisition rate increased to 11.5%, while the lapse rate declined to 10.1%. The combination matters: attracting new customers is useful only if a business also retains existing customers and manages acquisition costs. Customers may change providers because of premium increases, service issues or differences in coverage. Improving product clarity and claims experiences can therefore support profitability without relying exclusively on marketing expenditure.<\/p>\n<p>Medibank reported that 52% of its policyholders engaged with health and wellbeing services, and Live Better rewards participation increased 13% to 931,000. The business logic is to become more useful between claims by supporting prevention, everyday health and customer engagement. However, participation does not automatically establish lower claims costs or better clinical outcomes. The value of these programmes should be evaluated through customer experience, sustained engagement, measurable health results and their incremental costs.<\/p>\n<p>The group is pursuing healthcare delivery through Amplar Health, Myhealth and partnerships. FY2025 Medibank Health segment profit rose 27% to A$76.7 million. Growth creates opportunities for better access but also clinical governance, workforce and investment risks that differ from underwriting.<\/p>\n<p><strong>Related articles:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>4. Amplar Health and care delivery<\/h2>\n<p>Medibank has expanded beyond insurance into healthcare services through Amplar Health, including virtual health, homecare, prevention and community-based care. The wider Medibank Health segment also includes Myhealth primary care operations and investments in short-stay and mental health facilities. In FY2025 Medibank Health segment profit rose 27.0% to A$76.7 million, representing roughly 10% of group earnings on management&#8217;s presentation. The segment generated A$485.2 million of revenue, including A$146.1 million from Myhealth.<\/p>\n<p>The strategic rationale is that the insurer can support customers before, during and after treatment while also delivering services to governments and other organisations. Amplar Health&#8217;s network recorded 4.3 million health interactions and homecare programmes saved approximately 177,000 hospital bed days during FY2025, according to the annual report. These are operational measures, not direct measures of profit or proven clinical superiority. Delivering care introduces workforce, clinical governance and service-quality risks that differ from underwriting insurance. Medibank must balance the potential for integrated care with clear accountability and patient choice.<\/p>\n<p>The 2022 cybercrime event demonstrates why data protection is central to the insurer&#8217;s commercial proposition. APRA imposed a temporary A$250 million capital adjustment. Strong governance must accompany digital services and sensitive information handling.<\/p>\n<p><strong>Related articles:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>5. Financial performance and how money is made<\/h2>\n<p>For FY2025 revenue from ordinary activities excluding net investment income reached A$8,346.4 million, up 6.4%. The group reported A$500.8 million of statutory net profit after tax attributable to shareholders, up 1.7%, and A$618.7 million of underlying net profit after tax, up 8.5%. The difference between statutory and underlying results matters because underlying profit is a management-defined measure that adjusts specified items. The group also recorded A$207.8 million of net investment income, up 14.1%. Investment returns are an additional earnings source but can fluctuate with markets.<\/p>\n<p>Medibank&#8217;s profit is generated by managing the spread between insurance revenue and the costs of claims and administration, complemented by earnings from healthcare services and investment assets. Unlike a typical subscription business, an insurer must maintain capital to meet future claims and regulatory requirements. APRA&#8217;s prudential framework includes a temporary A$250 million supervisory capital adjustment following the 2022 cybercrime event. That constraint is important when assessing how much profit can be distributed or reinvested. Medibank declared fully franked ordinary dividends of 18.0 cents per share for FY2025, including a 10.2-cent final dividend.<\/p>\n<p>Affordability and sustainability must be considered together. Premiums need to fund eligible claims and operating costs, while customers need understandable cover and manageable out-of-pocket expenses. Medibank&#8217;s no-gap networks and prevention initiatives aim to improve value, but their outcomes require ongoing measurement.<\/p>\n<p><strong>Related articles:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h2>6. Future growth, regulation and resilience<\/h2>\n<p>Medibank&#8217;s strategic priorities in its annual report are delivering leading experiences, differentiating insurance, expanding in health and strengthening foundations. The company has committed A$50 million over five years to mental health initiatives and continued investment in hospital partnerships, virtual care and prevention. Its FY2026 outlook anticipated moderation in industry policyholder growth, with an objective to grow market share responsibly. The report forecast claims per policy unit growth of 2.6% to 2.9% for FY2026. These are forward-looking expectations rather than achieved results.<\/p>\n<p>The most important long-term tension is affordability. Rising treatment costs can require premium increases, but higher premiums may weaken customer retention or reduce access. Medibank must work with hospitals and other providers to improve care pathways and out-of-pocket outcomes without compromising clinical standards. Data protection is equally critical because health information is sensitive and the 2022 cybercrime incident remains relevant to risk management and trust. The company can grow as an integrated health business, but that opportunity depends on capital discipline, quality of care, cybersecurity and transparent reporting.<\/p>\n<p>FY2025 health insurance revenue reached A$8,011.7 million and the group paid A$6.6 billion in claims. These measures illustrate the scale of insurance obligations, but should not be reduced to a simple profit calculation because administrative costs, insurance accounting and capital requirements also matter.<\/p>\n<p><strong>Related articles:<\/strong> <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-business-strategy-2026\/\">Business Strategy<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-swot-analysis-2026\/\">SWOT Analysis<\/a> | <a href=\"https:\/\/thestrategystory.com\/blog\/medibank-pestel-analysis-2026\/\">PESTEL Analysis<\/a>.<\/p>\n<h3>Why claims experience determines the economics<\/h3>\n<p>An insurer receives premiums from a broad population of customers but pays claims unevenly as members use covered services. The timing and severity of claims can differ from forecasts, particularly when treatment costs rise or delayed care returns. Medibank&#8217;s FY2025 A$6.6 billion in claims paid demonstrates the scale of this obligation. Underwriting is not simply about maximising the difference between premiums and claims: community rating, risk equalisation and prudential capital requirements are fundamental constraints. The company must maintain adequate reserves and capital, assess claims trends and negotiate responsibly with providers. Customers ultimately judge the proposition by whether benefits are clear and available when needed. Sustainable profitability requires accurate pricing, efficient administration and genuine value rather than restricting access in ways that undermine trust.<\/p>\n<h3>Resident and non-resident insurance<\/h3>\n<p>Medibank&#8217;s insurance portfolio includes resident health insurance as well as products for overseas students and visitors. These groups have different eligibility, healthcare needs, coverage rules and distribution channels. The annual report identified net growth of 27,900 resident policyholders and 10,500 non-resident policy units in FY2025. The different units of measurement matter: a policy unit is not necessarily one person, and the economics of different products should not be combined without understanding their claims and administration costs. International education and travel activity can influence non-resident demand, while resident cover is more directly linked to household affordability and the Australian private health system. A diversified insurance portfolio can support growth but also increases operational complexity.<\/p>\n<h3>How provider agreements influence value<\/h3>\n<p>A health insurer cannot deliver good customer outcomes through policy design alone. Members need access to hospitals, clinicians and ancillary providers who can provide eligible services at reasonable cost. Medibank&#8217;s Members&#8217; Choice Advantage and no-gap arrangements were reported to have saved customers more than A$28 million in out-of-pocket costs in FY2025. These arrangements can make the benefits of membership tangible, but they do not mean that every treatment is free or that every provider participates. The insurer must negotiate prices and service terms while protecting clinical independence and customer choice. Provider relationships also affect claims inflation, patient experiences and the sustainability of the broader health system.<\/p>\n<h3>Prevention as a business-model extension<\/h3>\n<p>Prevention programmes create an additional way for Medibank to interact with customers before they need expensive treatment. In FY2025, 52% of Medibank policyholders engaged with health and wellbeing services and 931,000 people participated in Live Better rewards. Engagement can strengthen relationships and potentially encourage healthier behaviours, but these figures do not demonstrate that medical costs fell because of the programmes. Evaluating prevention requires appropriate measures of participation, clinical outcomes, customer satisfaction and incremental expenditure. A programme may be worthwhile because it improves wellbeing even when immediate claims savings are difficult to prove. Medibank should therefore distinguish the commercial value of retention from the clinical value of prevention.<\/p>\n<h3>Care delivery changes the risk profile<\/h3>\n<p>Amplar Health and Myhealth extend Medibank&#8217;s involvement beyond financing treatment into providing healthcare. This changes the operating model. Insurance underwriting relies heavily on actuarial, pricing and claims capabilities; care delivery requires clinicians, quality assurance, scheduling, patient safety and clinical governance. The FY2025 Medibank Health segment profit of A$76.7 million was growing faster than the mature insurance operation, but it remained smaller. Scaling virtual and homecare services may improve access, yet patients must be clinically appropriate for the chosen setting. The reported 177,000 hospital bed days saved through homecare programmes is a meaningful operational indicator, but should not be equated automatically with financial savings to Medibank. Revenue growth must be evaluated alongside patient outcomes and service quality.<\/p>\n<h3>Investment income and the capital base<\/h3>\n<p>Health insurers hold financial assets to support claims obligations, regulatory capital and liquidity needs. Medibank reported A$207.8 million in net investment income in FY2025, up 14.1%. These returns supplement operating earnings but are influenced by interest rates and investment markets. Management cannot assume that investment income will increase at the same pace every year. APRA requires insurers to assess capital adequacy and maintain a board-approved risk and capital framework. The temporary A$250 million capital adjustment after the cybercrime event further illustrates that regulatory resilience affects the amount of capital available for other uses. Investors should evaluate underwriting performance and investment returns separately before judging sustainable profitability.<\/p>\n<h3>Why the two profit measures differ<\/h3>\n<p>FY2025 statutory net profit after tax was A$500.8 million, while underlying net profit after tax was A$618.7 million. The adjusted measure is designed to help management explain ongoing business performance, but it is not a substitute for the audited statutory result. Non-recurring costs and other adjustments can be economically important even if they are excluded from an underlying metric. The same caution applies to segment operating profit: Medibank&#8217;s A$741.5 million Health Insurance operating profit and A$76.7 million Medibank Health segment profit should not simply be added and described as group statutory profit. Corporate costs, investment income, tax and accounting adjustments affect the consolidated result. Transparent reconciliations are essential for a credible analysis.<\/p>\n<h3>Long-term growth versus affordability<\/h3>\n<p>Medibank&#8217;s FY2026 outlook expected moderation in industry growth and forecast claims per policy unit growth of 2.6% to 2.9%. These were management expectations, not guaranteed outcomes. The central strategic challenge is balancing rising healthcare costs with customers&#8217; ability to pay. Premium increases can support claims funding but may cause policyholders to downgrade or cancel cover. Prevention, more efficient provider networks and alternative care settings may improve value, yet each requires evidence and investment. Medibank&#8217;s future depends on delivering health services that customers trust while maintaining the capital strength required of an insurer. Expansion into primary care and virtual health offers diversification, but the group must avoid confusing the number of health interactions with the quality or profitability of those interactions.<\/p>\n<p>The economics of health insurance are also shaped by the relationship between customer growth and the claims mix. Adding 27,900 resident policyholders does not guarantee proportionate profit growth, because different customers buy different levels of cover and make different claims. Community rating and risk equalisation constrain how risk is priced across the resident market. Medibank&#8217;s long-term opportunity is to retain customers through clear benefits, dependable service and access to appropriate providers. The FY2025 insurance operating profit of A$741.5 million provides a financial baseline, but investors should monitor claims trends, administrative efficiency and the cost of customer acquisition. The business model remains attractive only when premiums and investment income support obligations without making coverage unaffordable.<\/p>\n<p><strong>Source:<\/strong> <a href=\"https:\/\/www.medibank.com.au\/content\/dam\/retail\/about-assets\/pdfs\/investor-centre\/annual-reports\/Medibank_AnnualReport2025.pdf\">Medibank Annual Report 2025<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medibank Business Model in 2026: insurance, ahm, Amplar Health, FY2025 financial performance and healthcare risks.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[166],"tags":[],"class_list":{"0":"post-27471","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business-model"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medibank Business Model in 2026 - The Strategy Story<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medibank Business Model in 2026 - The Strategy Story\" \/>\n<meta property=\"og:description\" content=\"Medibank Business Model in 2026: insurance, ahm, Amplar Health, FY2025 financial performance and healthcare risks.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"The Strategy Story\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-22T04:03:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-22T04:05:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/03\/TSS-logo-11-modified.png\" \/>\n\t<meta property=\"og:image:width\" content=\"403\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shikhar Goel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shikhar Goel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/\",\"url\":\"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/\",\"name\":\"Medibank Business Model in 2026 - The Strategy Story\",\"isPartOf\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\"},\"datePublished\":\"2026-11-22T04:03:53+00:00\",\"dateModified\":\"2026-11-22T04:05:02+00:00\",\"author\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\"},\"breadcrumb\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thestrategystory.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medibank Business Model in 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\",\"url\":\"https:\/\/thestrategystory.com\/blog\/\",\"name\":\"The Strategy Story\",\"description\":\"Simplifying Business Strategies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071\",\"name\":\"Shikhar Goel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g\",\"caption\":\"Shikhar Goel\"},\"url\":\"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medibank Business Model in 2026 - The Strategy Story","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/","og_locale":"en_US","og_type":"article","og_title":"Medibank Business Model in 2026 - The Strategy Story","og_description":"Medibank Business Model in 2026: insurance, ahm, Amplar Health, FY2025 financial performance and healthcare risks.","og_url":"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/","og_site_name":"The Strategy Story","article_published_time":"2026-11-22T04:03:53+00:00","article_modified_time":"2026-11-22T04:05:02+00:00","og_image":[{"width":403,"height":403,"url":"https:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/03\/TSS-logo-11-modified.png","type":"image\/png"}],"author":"Shikhar Goel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Shikhar Goel","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/","url":"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/","name":"Medibank Business Model in 2026 - The Strategy Story","isPartOf":{"@id":"https:\/\/thestrategystory.com\/blog\/#website"},"datePublished":"2026-11-22T04:03:53+00:00","dateModified":"2026-11-22T04:05:02+00:00","author":{"@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071"},"breadcrumb":{"@id":"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thestrategystory.com\/blog\/medibank-business-model-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thestrategystory.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Medibank Business Model in 2026"}]},{"@type":"WebSite","@id":"https:\/\/thestrategystory.com\/blog\/#website","url":"https:\/\/thestrategystory.com\/blog\/","name":"The Strategy Story","description":"Simplifying Business Strategies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/8eed62769b0125006923a7fdc33f1071","name":"Shikhar Goel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8b6c6c1213b8835c1731c5d95c1ea3103684847f09cc6d1aab64d3e432f66481?s=96&d=mm&r=g","caption":"Shikhar Goel"},"url":"https:\/\/thestrategystory.com\/blog\/author\/tss-publisher\/"}]}},"_links":{"self":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/comments?post=27471"}],"version-history":[{"count":2,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27471\/revisions"}],"predecessor-version":[{"id":27479,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/27471\/revisions\/27479"}],"wp:attachment":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/media?parent=27471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/categories?post=27471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/tags?post=27471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}